Stock Price
2.25
Daily Change
0.04 1.58%
Monthly
-1.97%
Yearly
145.36%
Q3 Forecast
2.11

Mesoblast reported $-6457000 in Gross Profit on Sales for its fiscal semester ending in June of 2024.




Gross Profit On Sales Change Date
Avita Medical AUD 16.13M 3.05M Dec/2024
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Cochlear AUD 881.7M 14.5M Dec/2024
CSL USD 4.28B 939M Dec/2024
Pacific Edge NZD 283K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 414.94K 4.82M Dec/2024
PYC Therapeutics AUD 6.58M 2.13M Jun/2024
Ramsay Health Care AUD 6.32B 20.5M Dec/2024
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Starpharma Holdings AUD 2.08M 3.82M Dec/2024
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024